Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Hougaard

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Diabetologia|November 21, 2016
Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitusNasim Samandari, Aashiq H Mirza, Lotte B Nielsen, et al.
The American Journal of Medicine|March 11, 2008
Genetic variation and activity of the renin-angiotensin system and severe hypoglycemia in type 1 diabetesUlrik Pedersen-Bjergaard, Sukhbir S Dhamrait, Amar A Sethi, et al.
BMC Medical Genetics|March 25, 2011
The PTPN22 C1858T gene variant is associated with proinsulin in new-onset type 1 diabetesLotte B Nielsen, Sven Pörksen, Marie Louise M Andersen, et al.
Diabetes/Metabolism Research and Reviews|September 24, 2004
Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selectionUlrik Pedersen-Bjergaard, Stig Pramming, Simon R Heller, et al.
The Journal of Clinical Endocrinology and Metabolism|May 24, 2007
Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetesSven Pörksen, Lotte B Nielsen, Anne Kaas, et al.
Pediatric Diabetes|April 16, 2014
Disease progression among 446 children with newly diagnosed type 1 diabetes located in Scandinavia, Europe, and North America during the last 27 yrMarie Louise Max Andersen, Lotte B Nielsen, Jannet Svensson, et al.
The Lancet. Diabetes & Endocrinology|May 6, 2014
Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trialUlrik Pedersen-Bjergaard, Peter Lommer Kristensen, Henning Beck-Nielsen, et al.
Pediatric Diabetes|May 10, 2008
Variation within the PPARG gene is associated with residual beta-cell function and glycemic control in children and adolescents during the first year of clinical type 1 diabetesSven Pörksen, Lotte B Nielsen, Henrik B Mortensen, et al.
Diabetes Care|May 14, 2009
New definition for the partial remission period in children and adolescents with type 1 diabetesHenrik B Mortensen, Philip Hougaard, Peter Swift, et al.
Experimental Diabetes Research|July 26, 2012
Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progressionLotte B Nielsen, Cheng Wang, Kaspar Sørensen, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Diabetologia|November 21, 2016
Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitusNasim Samandari, Aashiq H Mirza, Lotte B Nielsen, et al.
The American Journal of Medicine|March 11, 2008
Genetic variation and activity of the renin-angiotensin system and severe hypoglycemia in type 1 diabetesUlrik Pedersen-Bjergaard, Sukhbir S Dhamrait, Amar A Sethi, et al.
BMC Medical Genetics|March 25, 2011
The PTPN22 C1858T gene variant is associated with proinsulin in new-onset type 1 diabetesLotte B Nielsen, Sven Pörksen, Marie Louise M Andersen, et al.
Diabetes/Metabolism Research and Reviews|September 24, 2004
Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selectionUlrik Pedersen-Bjergaard, Stig Pramming, Simon R Heller, et al.
The Journal of Clinical Endocrinology and Metabolism|May 24, 2007
Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetesSven Pörksen, Lotte B Nielsen, Anne Kaas, et al.
Pediatric Diabetes|April 16, 2014
Disease progression among 446 children with newly diagnosed type 1 diabetes located in Scandinavia, Europe, and North America during the last 27 yrMarie Louise Max Andersen, Lotte B Nielsen, Jannet Svensson, et al.
The Lancet. Diabetes & Endocrinology|May 6, 2014
Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trialUlrik Pedersen-Bjergaard, Peter Lommer Kristensen, Henning Beck-Nielsen, et al.
Pediatric Diabetes|May 10, 2008
Variation within the PPARG gene is associated with residual beta-cell function and glycemic control in children and adolescents during the first year of clinical type 1 diabetesSven Pörksen, Lotte B Nielsen, Henrik B Mortensen, et al.
Diabetes Care|May 14, 2009
New definition for the partial remission period in children and adolescents with type 1 diabetesHenrik B Mortensen, Philip Hougaard, Peter Swift, et al.
Experimental Diabetes Research|July 26, 2012
Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progressionLotte B Nielsen, Cheng Wang, Kaspar Sørensen, et al.
Pageof 3